Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest | Zendy

Peter J. Kudenchuk | Zendy; Brian G. Leroux | Zendy; Mohamud Daya | Zendy; Thomas D. Rea | Zendy; Christian Vaillancourt | Zendy; Laurie J. Morrison | Zendy; Clifton W. Callaway | Zendy; James Christenson | Zendy; Joseph P. Ornato | Zendy; James V. Dunford | Zendy; Lynn Wittwer | Zendy; Myron L. Weisfeldt | Zendy; Tom P. Aufderheide | Zendy; Gary M. Vilke | Zendy; Ahamed H. Idris | Zendy; Ian G. Stiell | Zendy; M. Riccardo Colella | Zendy; Tami Kayea | Zendy; Debra Egan | Zendy; Patrice DesvigneNickens | Zendy; Pamela C. Gray | Zendy; Randal Gray | Zendy; Ron Straight | Zendy; Paul Dorian | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest

Author(s) -

Peter J. Kudenchuk,

Brian G. Leroux,

Mohamud Daya,

Thomas D. Rea,

Christian Vaillancourt,

Laurie J. Morrison,

Clifton W. Callaway,

James Christenson,

Joseph P. Ornato,

James V. Dunford,

Lynn Wittwer,

Myron L. Weisfeldt,

Tom P. Aufderheide,

Gary M. Vilke,

Ahamed H. Idris,

Ian G. Stiell,

M. Riccardo Colella,

Tami Kayea,

Debra Egan,

Patrice DesvigneNickens,

Pamela C. Gray,

Randal Gray,

Ron Straight,

Paul Dorian

Publication year - 2017

Publication title -

circulation

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.117.028624

Subject(s) - medicine , cardiology , intensive care medicine , emergency medicine

Out-of-hospital cardiac arrest (OHCA) commonly presents with nonshockable rhythms (asystole and pulseless electric activity). It is unknown whether antiarrhythmic drugs are safe and effective when nonshockable rhythms evolve to shockable rhythms (ventricular fibrillation/pulseless ventricular tachycardia [VF/VT]) during resuscitation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research